Asustek Computer Inc (華碩) hopes the launch of its next-generation smartphone — the ZenFone 3 — in June will help boost growth momentum in the second half of this year, a company official said on Friday.
“We expect to introduce the new flagship smartphone at the end of June and start mass production in July,” Asustek chief financial officer Nick Wu (吳長榮) said in a telephone interview.
Together with the launches of other handsets in the second half of the year, the company aims to sell 25 million smartphones this year, an increase of 25 percent from last year’s 20 million units.
The company in February cut its annual shipment target for smartphones from 30 million units to 25 million units.
The smartphone business for the first half of the year is likely to remain flattish or increase slightly from the 8 million units sold over the same period last year, as the product cycle of the ZenFone 2 series gradually dissipates, the company said.
Analysts said the company would need to ship 17 million units between July and December to reach its annual target.
However, as the Zenfone series becomes more complete, it will serve as a stronger growth driver for Asustek, they said.
The company’s goal of a 25 percent annual increase in smartphone shipments is higher than the global average of 7 percent forecast by international research house Gartner Inc on March 31.
It also underlines chief executive officer Jerry Shen’s (沈振來) efforts to improve the firm’s smartphone marketing strategies.
Shen in February said that Asustek aims to focus on fast-growing emerging markets this year such as Indonesia, Malaysia, Vietnam, Thailand, the Philippines and India.
The firm also plans to introduce a limited number of higher-margin smartphones in the regions in a bid to have a deeper and closer relationship with consumers there, he said.
Shen said the company hopes to see its market share in Indonesia increase to 18 percent this year from 15 percent last year and from 2 percent to 5 percent in India.
Compared with the company’s aggressiveness in the smartphone business, Asustek is conservative about the outlook of its tablet segment, after seeing an annual decline of 37.23 percent in shipments last year amid softening demand.
In the first quarter of this year, the company only shipped 1 million tablets, down 33.33 percent from 1.5 million units a year ago, Wu said.
Wu said the company also plans to introduce new tablets in June and will continue improving its operation efficiency in the tablet segment in a bid to increase tablet shipments in the second half.
However, the persistent weak demand for tablets worldwide will weigh on Asustek’s tablet shipments this year, which are likely to remain flat from last year’s 5.9 million units, Wu said.
This time was supposed to be different. The memorychip sector, famous for its boom-and-bust cycles, had changed its ways. A combination of more disciplined management and new markets for its products — including 5G technology and cloud services — would ensure that companies delivered more predictable earnings. Yet, less than a year after memory companies made such pronouncements, the US$160 billion industry is suffering one of its worst routs ever. There is a glut of the chips sitting in warehouses, customers are cutting orders and product prices have plunged. “The chip industry thought that suppliers were going to have better control,” said
Enimmune Corp (安特羅生技) has obtained marketing approval from the Food and Drug Administration (FDA) for its EnVAX-A71 vaccine for enterovirus 71 (EV-71), becoming the nation’s first enterovirus vaccine completely made in Taiwan, it said yesterday. After spending 13 years and NT$1.5 billion (US$49.77 million) on the research and development of the vaccine, Enimmune plans to start manufacturing and marketing it by the end of March, the company said in a statement, without disclosing customer order figures. “It is possible that the vaccine would not be included in a national vaccination program initially, and consumers would need to pay for it themselves,” parent
Vaccine skeptics blocking transfusions for life-saving surgeries, Facebook groups inciting violence against doctors and a global search for unvaccinated donors — COVID-19 misinformation has bred a so-called “pure blood” movement. The movement spins anti-vaccine narratives focused on unfounded claims that receiving blood from people inoculated against COVID-19 “contaminates” the body. Some have advocated for blood banks that draw from “pure” unvaccinated people, while medics in North America say they have fielded requests from people demanding transfusions from donors who have not received a vaccine. In closed social media groups, vaccine skeptics — who brand themselves as “pure bloods” — promote violence against doctors
Asteroid mining start-up AstroForge Inc is planning to launch its first two missions to space this year as it seeks to extract and refine metals from deep space. The first launch, scheduled for April, is to test AstroForge’s technique for refining platinum from a sample of asteroid-like material. The second, planned for October, would scout for an asteroid near Earth to mine. The missions are part of AstroForge’s goal of refining platinum-group metals from asteroids, with the aim of bringing down the cost of mining these metals. It also hopes to reduce the massive amount of carbon emissions that stem from mining
RSS